100% of Patients On IMX-110 Completed Planned Treatment Cycles

100% of Patients On IMX-110 Completed Planned Treatment Cycles

Immix Biopharma, Inc. (NASDAQ:IMMX)

Format

PNG

Source

Immix Biopharma, Inc.

Téléchargements